結腸直腸がん診断市場の主要企業は、結腸直腸がんや、結腸ポリープ、クローン病、大腸炎、過敏性腸症候群などのその他の関連疾患の負担を軽減するのに役立つ幅広いデバイスを製造しています。 2022 年 7 月、一流の胃腸 (GI) 診療ネットワークである US Digestive Health (USDH) は、国内最大の Genious Intelligent GI 内視鏡モジュールを導入した AI 支援結腸内視鏡検査の商業化を発表しました。これらのモジュールは、医師が検出が困難な癌性の可能性のあるポリープをリアルタイムで特定するのに役立つと期待されています。このデバイスの発売により、ペンシルベニア州南東部、南西部、中央部の患者は、機能が強化された AI 支援結腸内視鏡検査にアクセスできるようになりました。オリンパス株式会社は2020年9月、人工知能(AI)を活用した最先端のプラットフォーム「ENDO-AID」の提供開始を発表した。このプラットフォームには、結腸のさまざまな状態を検出するためのコンピューター支援内視鏡法である ENDO-AID CADe アプリケーション (アプリ) が含まれています。この新しい AI プラットフォームは、自動的に検出された疑わしい病変のリアルタイム表示を可能にし、EVIS X1 と組み合わせて機能します。したがって、頻繁な開発と新製品の発売により、北米の結腸直腸がん診断市場の成長が促進されます。
北米の結腸直腸がん診断市場は、モダリティに基づいて画像検査と便ベースの検査に二分されます。 2023 年には、画像検査セグメントが北米の結腸直腸がん診断市場で大きなシェアを獲得しました。画像検査セグメントの市場は、結腸内視鏡検査、CT コロノグラフィー、軟性 S 状結腸鏡検査、カプセル内視鏡検査などにさらに分類されます。便ベースの検査セグメントの市場は、便免疫化学検査 (fit)、グアヤックベースの便潜血検査 (gFOBT)、および便 DNA 検査にサブセグメント化されています。
North America Colorectal Cancer Diagnostics Strategic Insights
Strategic insights for North America Colorectal Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
North America Colorectal Cancer Diagnostics Report Scope
North America Colorectal Cancer Diagnostics Regional Insights
The regional scope of North America Colorectal Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - North America Colorectal Cancer Diagnostics Market
Bruker Corp
Clinical Genomics Technologies Pty Ltd
EDP Biotech Corp
Eiken Chemical Co., Ltd.
Epigenomics AG
F. Hoffmann-La Roche Ltd
Illumina Inc
Medtronic Plc
Quest Diagnostics Inc
Siemens Healthineers AG
Frequently Asked Questions
How big is the North America Colorectal Cancer Diagnostics Market?
The North America Colorectal Cancer Diagnostics Market is valued at US$ 4,315.86 Million in 2023, it is projected to reach US$ 6,621.26 Million by 2028.
What is the CAGR for North America Colorectal Cancer Diagnostics Market by (2023 - 2028)?
As per our report North America Colorectal Cancer Diagnostics Market, the market size is valued at US$ 4,315.86 Million in 2023, projecting it to reach US$ 6,621.26 Million by 2028. This translates to a CAGR of approximately 8.9% during the forecast period.
What segments are covered in this report?
The North America Colorectal Cancer Diagnostics Market report typically cover these key segments-
検査法 (画像検査, 便検査)
エンドユーザー (病院, 診断研究所, がん研究機関)
What is the historic period, base year, and forecast period taken for North America Colorectal Cancer Diagnostics Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Cancer Diagnostics Market report:
Historic Period : 2021-2022
Base Year : 2023
Forecast Period : 2024-2028
Who are the major players in North America Colorectal Cancer Diagnostics Market?
The North America Colorectal Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Bruker Corp
Clinical Genomics Technologies Pty Ltd
EDP Biotech Corp
Eiken Chemical Co., Ltd.
Epigenomics AG
F. Hoffmann-La Roche Ltd
Illumina Inc
Medtronic Plc
Quest Diagnostics Inc
Siemens Healthineers AG
Who should buy this report?
The North America Colorectal Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the North America Colorectal Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For North America Colorectal Cancer Diagnostics Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines